Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06552871 · ClinicalTrials.gov registry record · NA
Participatory Research for Suicide Prevention in Autism
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT06552871: Completed NA study, sponsored by University of Utah.
NCT06552871 is a NA study that has completed, run by University of Utah. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06552871, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The goal of this study is to pilot test a new educational intervention for organization members focused on suicide prevention for autistic people. The main questions it aims to answer are: * Does participating in the intervention increase participants' knowledge, skills, and actions to support suicide prevention for autistic people? * What feedback do participants have to help improve the intervention? Participants will: * engage in a four-part virtual educational intervention * answer questions via online survey before, after, and 3-months after the intervention * participate in an optional interview to provide feedback
Primary Outcome
Self-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Knowledge \& Capacity scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This scale inquires about how true eight statements are for the respondent currently on a 5-point scale (Definitely not true - Definitely true). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater knowledge and capacity
Interventions
- BEHAVIORAL Forming Love around Autistic People to Prevent Suicide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2025-08-05 |
| Phase | NA |
What the finished NCT06552871 record still lists
NCT06552871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Forming Love around Autistic People to Prevent Suicide is the first listed.
NCT06552871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06552871 about?
NCT06552871 is a clinical study titled "Participatory Research for Suicide Prevention in Autism". The goal of this study is to pilot test a new educational intervention for organization members focused on suicide prevention for autistic people. The main questions it aims to answer are: * Does participating in the intervention increase participants' knowledge, skills, and actions to support suic...
What is the current status of trial NCT06552871?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2024-09-05. Estimated completion is 2025-08-05.
What interventions are being tested in trial NCT06552871?
The interventions under investigation include: Forming Love around Autistic People to Prevent Suicide (BEHAVIORAL).
Who is sponsoring clinical trial NCT06552871?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06552871's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI